|
| Press Releases |
|
 |
|
| Tuesday, May 30, 2023 |
|
|
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China |
| On May 30, China Medical System Holdings Limited ("CMS" or the "Group") announced that on 26 May 2023, the New Drug Application (NDA) of Tildrakizumab Injection under the brand name of ILUMETRI has been approved by the National Medical Products Administration of China (NMPA). ILUMETRI is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. more info >> |
|
|
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China |
| On May 30, China Medical System Holdings Limited ("CMS" or the "Group") announced that on 26 May 2023, the New Drug Application (NDA) of Tildrakizumab Injection under the brand name of ILUMETRI has been approved by the National Medical Products Administration of China (NMPA). ILUMETRI is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. more info >> |
|
| Monday, December 19, 2022 |
|
|
Gelonghui Reports CMS' Successful Phase III Study of Methylthioninium Chloride Enteric-coated Sustained-release Tablets |
| Gelonghui released a Press Release on "China Medical System Holdings Limited's innovative product Methylthioninium Chloride Enteric-coated Sustained-release Tablets ('the Product') has obtained positive results for its Phase III clinical trial in China." more info >> |
|
| Friday, November 18, 2022 |
|
|
China Medical System (867.HK) S&P Global CSA Score Achieved Significant Improvement, Leading the Industry Globally |
| Recently, the S&P Global Corporate Sustainability Assessment (S&P Global CSA) released the 2022 Environmental, Social and Governance (ESG) scores for China Medical System Holdings Limited ("CMS" or the "Group"). CMS achieved a significant improvement with a score of 53 in 2022 from 36 in 2021, surpassing 92% of the global peers and being significantly ahead of the industry average. more info >> |
|
| Tuesday, September 6, 2022 |
|
|
CMS Releases Its 2022 Interim Report, Achieves Sustained Growth with Its Platform Strategy |
| more info >> |
|
| Friday, August 26, 2022 |
|
|
CMS Releases Its 2022 Interim Report, Achieves Sustained Growth with Its Platform Strategy |
| more info >> |
|
| Monday, April 26, 2021 |
|
|
Starting its Industrial Investment in Biotech Companies, China Medical System (0867.HK) has Accelerated its Flywheel of Innovation |
| China Medical System Holdings Limited (0867.HK) ("CMS" or the "Company") has been active in the market this year. more info >> |
|
|
泰諾麥博宣佈完成4.5億元人民幣A輪融資 |
| 近日，珠海泰諾麥博生物技術有限公司（Trinomab Biotech Co., Ltd. 簡稱“泰諾麥博”或“Trinomab”）宣佈完成4.5億元人民幣的A輪融資，此次融資由高瓴創投領投，康哲藥業、藥明生物產業基金、無錫國聯等共同參與完成。 more info >> |
|
|
泰诺麦博宣布完成4.5亿元人民币A轮融资 |
| 近日，珠海泰诺麦博生物技术有限公司（Trinomab Biotech Co., Ltd. 简称“泰诺麦博”或“Trinomab”）宣布完成4.5亿元人民币的A轮融资，此次融资由高瓴创投领投，康哲药业、药明生物产业基金、无锡国联等共同参与完成。 more info >> |
|
| Monday, April 5, 2021 |
|
|
China Medical System (0867.HK) Accelerating Development and Stepping to New Heights, Driven by Innovation |
| As the earning season approaches, once again listed pharmaceutical companies are attracting the attention of the public. Recently, China Medical System Holdings Limited ("CMS" or the "Company") has released its annual results, with both revenue and profit higher than market expectations. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
International Confederation of Midwives to Host Thousands of Delegates at Its 33rd Triennial Congress in Bali
Jun 8, 2023 23:00 HKT/SGT
|
|
|
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, progresses at full speed in innovative research and development, Presents major research results of birociclib, the start product, at the international stage in ASCO
Jun 8, 2023 21:18 HKT/SGT
|
|
|
四环医药旗下轩竹生物创新研发全速前进 携明星产品吡罗西尼重磅研究成果登国际舞台于ASCO亮相
Jun 8, 2023 21:16 HKT/SGT
|
|
|
四環醫藥旗下軒竹生物創新研發全速前進 攜明星產品吡羅西尼重磅研究成果登國際舞台於ASCO亮相
Jun 8, 2023 21:15 HKT/SGT
|
|
|
Doubleview Resumes Diamond Drilling Exploration at Hat Project
Jun 8, 2023 21:05 HKT/SGT
|
|
|
Doubleview Resumes Diamond Drilling Exploration at Hat Project
Jun 8, 2023 21:00 HKT/SGT
|
|
|
Hitachi launches "Hitachi Application Reliability Centers Service" in Japan to enable cloud-native operations to drive both agility and reliability
Jun 8, 2023 16:50 JST
|
|
|
The Philippines' top-line cybersecurity event, PhilSec now backed by CyberSecurity Philippines CERT & WiSAP
Jun 8, 2023 14:07 HKT/SGT
|
|
|
Internationally Acclaimed Benns Chocolate Launches Single-Origin Chocolate Evoking Malaysian Flavours
Jun 8, 2023 14:00 HKT/SGT
|
|
|
LEXUS、「LC」を一部改良するとともに特別仕様車“EDGE”を発売
Jun 8, 2023 13:30: JST
|
|
|
Eisai Files Marketing Authorization Application for Lecanemab as Treatment For Early Alzheimer's Disease in South Korea
Jun 8, 2023 13:32 JST
|
|
|
Famed Photographer David Christopher Lee to Give Away NFTs of Iconic Photos Over the Month of June
Jun 8, 2023 09:47 HKT/SGT
|
|
|
エーザイ、抗アミロイドβプロトフィブリル抗体「レカネマブ」について、韓国において早期アルツハイマー病に係る適応で新薬承認を申請
Jun 8, 2023 09:00: JST
|
|
|
Taiwan Excellence Showcases over 30 Award-Winning Products at Asia Tech x Singapore 2023 Debut
Jun 8, 2023 09:00 HKT/SGT
|
|
|
Empower Your Journey: BLUETTI AC60 Redefines Portable Energy for the Aussie Explorer
Jun 8, 2023 09:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
